https://pharmadevresearch.com/ weekly 1 https://pharmadevresearch.com/es weekly 0.9 https://pharmadevresearch.com/for-patients 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/for-patients 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/for-sponsors monthly 0.8 https://pharmadevresearch.com/es/for-sponsors monthly 0.7000000000000001 https://pharmadevresearch.com/about monthly 0.7 https://pharmadevresearch.com/es/about monthly 0.6 https://pharmadevresearch.com/team monthly 0.7 https://pharmadevresearch.com/es/team monthly 0.6 https://pharmadevresearch.com/contact monthly 0.7 https://pharmadevresearch.com/es/contact monthly 0.6 https://pharmadevresearch.com/articles monthly 0.8 https://pharmadevresearch.com/es/articles monthly 0.7000000000000001 https://pharmadevresearch.com/clinical-trials/narcolepsy 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/clinical-trials/narcolepsy 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/clinical-trials/idiopathic-hypersomnia 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/clinical-trials/idiopathic-hypersomnia 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/clinical-trials/sleep-apnea 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/clinical-trials/sleep-apnea 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/clinical-trials/obesity 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/clinical-trials/obesity 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/clinical-trials/shift-work-disorder 2026-09-26T00:00:00.000Z weekly 0.9 https://pharmadevresearch.com/es/clinical-trials/shift-work-disorder 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/for-patients/alks-2680-narcolepsy-type-1 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/alks-2680-narcolepsy-type-1 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/alks-narcolepsy-type-2 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/alks-narcolepsy-type-2 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/hbs-narcolepsy 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/hbs-narcolepsy 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/hbs-idiopathic-hypersomnia 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/hbs-idiopathic-hypersomnia 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/tak-narcolepsy-type-1 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/tak-narcolepsy-type-1 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/tak-narcolepsy-type-2 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/tak-narcolepsy-type-2 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/orx750-narcolepsy-ih 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/orx750-narcolepsy-ih 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/cleminorexton-hypersomnolence 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/cleminorexton-hypersomnolence 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/xywav-narcolepsy-ih 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/xywav-narcolepsy-ih 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/osa-obesity-eloralintide 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/osa-obesity-eloralintide 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/osa-obesity-weight-loss 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/osa-obesity-weight-loss 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/zenagamtide-obesity 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/zenagamtide-obesity 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/genio-osa-implant 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/genio-osa-implant 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/osa-sensor-study 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/osa-sensor-study 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/for-patients/solriamfetol-shift-work 2026-09-26T00:00:00.000Z weekly 0.8 https://pharmadevresearch.com/es/for-patients/solriamfetol-shift-work 2026-09-26T00:00:00.000Z weekly 0.7000000000000001 https://pharmadevresearch.com/articles/excessive-daytime-sleepiness monthly 0.7 https://pharmadevresearch.com/es/articles/excessive-daytime-sleepiness monthly 0.6 https://pharmadevresearch.com/articles/when-cpap-does-not-work monthly 0.7 https://pharmadevresearch.com/es/articles/when-cpap-does-not-work monthly 0.6 https://pharmadevresearch.com/articles/what-is-a-sleep-study monthly 0.7 https://pharmadevresearch.com/es/articles/what-is-a-sleep-study monthly 0.6 https://pharmadevresearch.com/articles/what-happens-in-a-clinical-trial monthly 0.7 https://pharmadevresearch.com/es/articles/what-happens-in-a-clinical-trial monthly 0.6 https://pharmadevresearch.com/articles/will-i-get-a-placebo monthly 0.7 https://pharmadevresearch.com/es/articles/will-i-get-a-placebo monthly 0.6 https://pharmadevresearch.com/articles/what-is-an-open-label-extension monthly 0.7 https://pharmadevresearch.com/es/articles/what-is-an-open-label-extension monthly 0.6 https://pharmadevresearch.com/articles/obesity-and-sleep-apnea monthly 0.7 https://pharmadevresearch.com/es/articles/obesity-and-sleep-apnea monthly 0.6 https://pharmadevresearch.com/articles/what-happens-in-a-weight-loss-study monthly 0.7 https://pharmadevresearch.com/es/articles/what-happens-in-a-weight-loss-study monthly 0.6 https://pharmadevresearch.com/articles/shift-work-and-sleep monthly 0.7 https://pharmadevresearch.com/es/articles/shift-work-and-sleep monthly 0.6